Techs Loanstar, Inc. Announces Corporate Name Change to Quture International, Inc.03/15/2012 | Press Release
Quture, Inc. Is Wholly Owned Operations Subsidiary
WEST PALM BEACH, FL--(Marketwire -03/15/12)- Techs Loanstar, Inc. (OTCQB: TCLN.PK - News) (Pinksheets: TCLN.PK - News) announced today that The State of Nevada approved the Company's requested corporate name change to Quture International, Inc. ("Parent"). The Board of Directors recently approved and gave authority for the name change by a majority of the Company's shareholders. Quture, Inc. ("Quture") will remain a wholly owned subsidiary of Quture International, Inc. and be responsible for the operations of the Parent for development and marketing of its transformational clinical performance and outcomes software and technology.
Quture International, Inc. is now in the process of filing the name change as well as a new ticker symbol with the appropriate regulatory bodies to better reflect the Company's core business. Announcement details will be released regarding the process and timing for the new name in the markets, as well as the new symbol, as the Company goes through the regulatory process. Until then, the Company will continue to trade under the symbol TCLN.
"We derived the name Quture by substituting the first letter 'F' in 'future' with the letter 'Q' from the word 'quality.' The name of the Company is intended to convey the magnitude of the opportunities of Quture to become the future of quality health and health care internationally," said Landon Feazell, Chairman and CEO of Quture International, Inc. He added: "This is just the first step in major transitions ahead for our Company. Our name change to Quture International, Inc. signals the real beginning to transitioning from product development and demonstration into our intention to become the international standard of performance enhancement and makes perfect sense in our corporate development. With Quture, the wholly owned subsidiary for operations, the name change begins to pave the way for other anticipated business opportunities and reflects our current strategic plans to build long-term shareholder value."
QUTURE INTERNATIONAL, INC.
Quture International, Inc. is an emerging growth company positioned to become the leading clinical knowledge company in the world. The core competence of Quture is clinical performance enhancement to achieve optimal patient outcomes. Quture's brand is centered on the value proposition of trust, transparency and independence. As the free enterprise solution to improving health and health care while reducing costs, Quture is comprised of a subsidiary for the operations of its software technology solutions, plans for a "beyond data" consulting and knowledge applications company, as well as plans for a personalized, proactive, and predictive medicine company with a virtual community of members. These subsidiaries will all be affiliated with the Qx Medical Exchange, which the Company intends to become the largest medical and health exchange in the world. Quture International is a Nevada corporation currently trading under the symbol TCLN.
Quture, Inc. is the operations subsidiary of Quture International, Inc., positioned to become the international standard in health care performance, outcomes and analytics. Quture's transformational product QualOptima operates on the InterSystems technology platform, the leading software platform globally for health care. QualOptima is the transcendent healthcare analytics system for performance enhancement to achieve optimal patient outcomes. The analytics system measures performance against evidence-based optimal clinical processes of care. The clinical data repository of QualOptima, the Qualytx integrated aggregate clinical database, is planned to become the international common data platform for health and health care. Qualytx will then be capable of transforming personal health and health care through knowledge solutions founded on Quture's proprietary science of knowing what to measure, where that data resides in disparate databases, using the InterSystems technology to electronically abstract that data, and converting data to knowledge and actionable insight with its revolutionary and proprietary analytics system. As America transitions to payment for value and U.S. and international pressures converge to measure performance, Quture will navigate the future of global health and healthcare quality, patient safety and value.
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.
For Further Information
Constellation Asset Advisors, Inc.
+1 (415) 524-8500
Director of Communications
« back to news page